DivestmentApr 16, 2026, 06:11 AM
CareDx Sells Kitted Lab Products Business for $170M Cash
AI Summary
CareDx, Inc. has entered into a Purchase Agreement with Eurobio Scientific S.A. to divest its kitted laboratory products business and related software. The transaction, valued at $170 million in cash, includes the sale of CareDx AB, a wholly-owned Swedish subsidiary. The deal is subject to customary closing conditions, including regulatory approval, and is expected to close by October 15, 2026.
Key Highlights
- CareDx to sell its kitted laboratory products business and related software.
- Transaction value is $170 million in cash.
- Sale includes shares of CareDx AB, a Swedish subsidiary.
- Eurobio Scientific S.A. is the buyer.
- Closing conditions include regulatory approval and no material adverse effect.